Form 4 for SYY Sysco
Accepted 2026-09-15 17:10:40 ET · period of report 2026-09-11 · accession 0001861524-26-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-09-15 17:10 | 2026-09-11 | SYY | Phillips Ronald L | EVP, CHRO | M - OptEx | $69.95 | +960 | 50.8K | +2% | +$67.2K |
| DMT | 2026-09-15 17:10 | 2026-09-11+ | SYY | Phillips Ronald L | EVP, CHRO | S - Sale+OE | $83.07 | -1,017 | 49.6K | -2% | -$84.5K |
| DT | 2026-09-15 17:10 | 2026-09-11 | SYY | Phillips Ronald L | EVP, CHRO | F - Tax | $82.31 | -149 | 49.7K | -0.3% | -$12.3K |
| DT | 2026-09-15 17:10 | 2026-09-11 | SYY | Phillips Ronald L | EVP, CHRO | M - OptEx | $0.00 | -960 | 1 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-11 | M | A | 960 | $69.95 | 50,811.66 | D | — | — | (F1) The exercises and sales were effected pursuant to a Rule 10b5-1 trading plan. |
| 2 | Common | Common Stock | 2026-09-11 | S | D | 960 | $83.00 | 49,851.66 | D | — | — | (F1) The exercises and sales were effected pursuant to a Rule 10b5-1 trading plan. |
| 3 | Common | Common Stock | 2026-09-11 | F | D | 149 | $82.31 | 49,702.66 | D | — | — | (F2) These shares were withheld upon the vesting of restricted stock units to pay tax withholding obligations. |
| 4 | Common | Common Stock | 2026-09-14 | S | D | 57 | $84.32 | 49,645.66 | D | — | — | (F3) The sale was effected pursuant to a Rule 10b5-1 trading plan. |
| 5 | Derivative | Stock Options (Right to buy) | 2026-09-11 | M | D | 960 | $0.00 | 1 | D | $69.95 · — to 2033-09-10 | 960 Common Stock | (F1) The exercises and sales were effected pursuant to a Rule 10b5-1 trading plan. (F5) Options granted by the Compensation and Leadership Development Committee of the Company's Board of Directors pursuant to the 2018 Omnibus Incentive Plan. (F4) One-third of the shares covered by the grant vest and are exercisable on 9/11/2024, 9/11/2025 and 9/11/2026, respectively. No options may be exercised prior to 9/11/2024. Options will expire on 9/10/2033. |